论文部分内容阅读
目的:探索在消化不良患者的临床治疗中,复方阿嗪米特的具体应用效果。方法:选择我院于2015年8月至2016年10月期间收治的56例患有消化不良的患者为对象,将所有患者随机均分作对照组和复方组,对照组患者接受安慰剂治疗,复方组患者则接受复方阿嗪米特治疗,对两组患者的临床治疗效果进行对比分析。结果:复方组患者的临床治疗效果明显好于对照组,两组患者的相关治疗数据接受对比后存在明显差异(P<0.05)。结论:在临床患有消化不良患者的具体治疗中,复方阿嗪米特的应用效果较好,值得推广。
Objective: To explore the clinical application of compound azinamazole in the clinical treatment of patients with dyspepsia. Methods: Fifty-six patients with dyspepsia admitted from August 2015 to October 2016 in our hospital were selected as subjects. All patients were randomly divided into control group and compound group, and patients in control group received placebo. Patients in the compound group were treated with compound azintomide, and the clinical effects of the two groups were compared. Results: The clinical efficacy of the compound group was significantly better than that of the control group. There was a significant difference (P <0.05) between the two groups in the treatment data after receiving the comparison. Conclusion: In the specific clinical treatment of patients with dyspepsia, the compound azinimitil has good effect and is worth promoting.